GSK plc announced with effect from 11 March 2024, Dr. Hal Dietz has been appointed a member of the Nominations & Corporate Governance Committee. This appointment is in addition to his role as Chair of the Science Committee and membership of the Chairs' Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,774 GBX | -0.20% | -0.03% | +22.36% |
06:02pm | British Stocks Extend Losing Streak Amid Retail Sales Slump | MT |
10:53am | Rate outlook weighs on equities |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.36% | 9.22TCr | |
+38.71% | 73TCr | |
+33.05% | 60TCr | |
-5.53% | 36TCr | |
+19.15% | 33TCr | |
+1.60% | 28TCr | |
+16.00% | 24TCr | |
+8.09% | 21TCr | |
-5.77% | 21TCr | |
+6.69% | 16TCr |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK plc Appoints Hal Dietz as Member of Nominations & Corporate Governance Committee, Effective 11 March 2024